Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|August 28, 2007
2B or not 2B? Disparate discrimination of functional VWF discordance using different assay panels or methodologies may lead to success or failure in the early identification of type 2B VWDEmmanuel J Favaloro, Roslyn Bonar, Muriel Meiring, et al.
Pathology|May 5, 2015
The effect of dabigatran on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samplesRoslyn Bonar, Emmanuel J Favaloro, Soma Mohammed, et al.
Seminars in Thrombosis and Hemostasis|February 20, 2010
Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitorsEmmanuel J Favaloro, Roslyn Bonar, Geoffrey Kershaw, et al.
American Journal of Clinical Pathology|June 24, 2003
Laboratory diagnosis of von Willebrand disorder. Current practice in the southern hemisphereEmmanuel J Favaloro, Roslyn Bonar, John Sioufi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 22, 2020
Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effectsEmmanuel J Favaloro, Grace Gilmore, Roslyn Bonar, et al.
Clinical Chemistry and Laboratory Medicine|March 4, 2020
Laboratory testing for activated protein C resistance: rivaroxaban induced interference and a comparative evaluation of andexanet alfa and DOAC Stop to neutralise interferenceEmmanuel J Favaloro, Grace Gilmore, Roslyn Bonar, et al.
Pathology|March 30, 2016
The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samplesRoslyn Bonar, Emmanuel J Favaloro, Soma Mohammed, et al.
Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology|January 15, 2008
The diagnostic dilemma: dual presentations of clinical mucosal bleeding and venous thrombosis associated with the presence of thrombophilia markers and mild reduction in von Willebrand factorEmmanuel J Favaloro, Roslyn Bonar, Lesley Survela, et al.
Pathology|December 21, 2011
Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAPRoslyn Bonar, Emmanuel Favaloro, Diane Zebeljan, et al.
Seminars in Thrombosis and Hemostasis|July 25, 2006
Reducing errors in identification of von Willebrand disease: the experience of the royal college of pathologists of australasia quality assurance programEmmanuel J Favaloro, Roslyn Bonar, Geoff Kershaw, et al.
Pageof 3